US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 3.440
  • -0.250-6.78%
Close Mar 28 16:00 ET
162.45MMarket Cap-2.69P/E (TTM)

Silence Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
36.71%43.26M
649.90%24.33M
-55.23%1.53M
-93.41%756.35K
11.19%15.66M
46.12%31.64M
-56.35%3.24M
-9.31%3.41M
159.88%11.48M
87.42%14.09M
Operating revenue
36.71%43.26M
649.90%24.33M
-55.23%1.53M
-93.41%756.35K
11.19%15.66M
46.12%31.64M
-56.35%3.24M
-9.31%3.41M
159.88%11.48M
87.42%14.09M
Cost of revenue
-8.21%11.81M
-16.36%1.61M
89.33%3.71M
-6.56%3.34M
-50.25%2.79M
-4.43%12.87M
-65.85%1.92M
-26.66%1.96M
25.17%3.57M
87.91%5.62M
Gross profit
67.49%31.45M
1,616.39%22.72M
-250.29%-2.18M
-132.61%-2.58M
51.91%12.87M
129.20%18.78M
-26.87%1.32M
33.19%1.45M
405.30%7.91M
87.09%8.47M
Operating expense
13.79%81.03M
27.48%12.06M
65.07%27.98M
-7.91%20.59M
-22.97%18.12M
19.86%71.21M
-14.03%9.46M
3.96%16.95M
19.88%22.36M
33.92%23.52M
Selling and administrative expenses
2.52%26.88M
-11.04%5.4M
23.93%7.49M
3.67%6.69M
-18.29%6.53M
2.10%26.22M
-20.80%6.06M
-7.07%6.05M
16.96%6.45M
5.47%7.99M
-General and administrative expense
2.52%26.88M
-11.04%5.4M
23.93%7.49M
3.67%6.69M
-18.29%6.53M
2.10%26.22M
-20.80%6.06M
-7.07%6.05M
16.96%6.45M
5.47%7.99M
Research and development costs
19.22%67.88M
32.96%20.4M
87.90%20.48M
-12.60%13.91M
-25.38%11.59M
30.74%56.94M
16.53%15.35M
11.29%10.9M
21.11%15.91M
55.50%15.53M
Other operating expenses
-14.96%-13.74M
----
----
----
----
-21.68%-11.95M
----
----
----
----
Operating profit
5.44%-49.58M
230.96%10.66M
-94.65%-30.16M
-60.37%-23.17M
65.13%-5.25M
-2.37%-52.43M
11.50%-8.14M
-1.86%-15.49M
15.43%-14.45M
-15.45%-15.05M
Net non-operating interest income expense
148.03%4.47M
1,871.74%12.43M
-510.15%-10.2M
259.94%1.12M
253.88%998.64K
543.93%1.8M
111.15%630.49K
-48.16%2.49M
-185.96%-697.5K
-241.16%-648.98K
Non-operating interest income
148.03%4.47M
73.18%886.95K
-47.41%1.31M
214.10%1.35M
143.92%1.02M
543.93%1.8M
109.00%512.14K
-48.36%2.5M
-47.15%428.84K
-9.49%416.14K
Non-operating interest expense
----
----
117,834.03%11.51M
-79.45%231.46K
-98.46%16.41K
----
----
-74.29%9.76K
--1.13M
--1.07M
Other net income (expense)
124.46%646K
-304.10%-2.64M
Gain on sale of security
124.46%646K
----
----
----
----
-304.10%-2.64M
----
----
----
----
Income before tax
16.53%-44.46M
333.88%23.74M
-210.27%-40.36M
-45.62%-22.06M
72.93%-4.25M
-7.30%-53.27M
25.14%-10.15M
-24.90%-13.01M
6.93%-15.15M
-24.83%-15.7M
Income tax
-11.61%845K
7.76%9.56M
-43.12%-4.21M
-17.10%-2.38M
38.52%-1.88M
38.95%956K
27.99%8.87M
-18.50%-2.94M
-12.98%-2.03M
-23.30%-3.06M
Net income
16.45%-45.31M
174.51%14.17M
-259.11%-36.15M
-50.03%-19.68M
81.26%-2.37M
-7.74%-54.23M
7.16%-19.02M
-26.90%-10.07M
9.40%-13.12M
-25.21%-12.64M
Net income continuous Operations
16.45%-45.31M
174.51%14.17M
-259.11%-36.15M
-50.03%-19.68M
81.26%-2.37M
-7.74%-54.23M
7.16%-19.02M
-26.90%-10.07M
9.40%-13.12M
-25.21%-12.64M
Minority interest income
Net income attributable to the parent company
16.45%-45.31M
174.51%14.17M
-259.11%-36.15M
-50.03%-19.68M
81.26%-2.37M
-7.74%-54.23M
7.16%-19.02M
-26.90%-10.07M
9.40%-13.12M
-25.21%-12.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.45%-45.31M
174.51%14.17M
-259.11%-36.15M
-50.03%-19.68M
81.26%-2.37M
-7.74%-54.23M
7.16%-19.02M
-26.90%-10.07M
9.40%-13.12M
-25.21%-12.64M
Basic earnings per share
32.65%-0.99
160.89%0.3067
-183.09%-0.7668
-15.95%-0.4212
84.98%-0.053
5.77%-1.47
15.37%-0.5037
-12.29%-0.2709
24.94%-0.3633
-4.15%-0.353
Diluted earnings per share
32.65%-0.99
160.89%0.3067
-183.09%-0.7668
-15.95%-0.4212
84.98%-0.053
5.77%-1.47
15.37%-0.5037
-12.29%-0.2709
24.94%-0.3633
-4.15%-0.353
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 36.71%43.26M649.90%24.33M-55.23%1.53M-93.41%756.35K11.19%15.66M46.12%31.64M-56.35%3.24M-9.31%3.41M159.88%11.48M87.42%14.09M
Operating revenue 36.71%43.26M649.90%24.33M-55.23%1.53M-93.41%756.35K11.19%15.66M46.12%31.64M-56.35%3.24M-9.31%3.41M159.88%11.48M87.42%14.09M
Cost of revenue -8.21%11.81M-16.36%1.61M89.33%3.71M-6.56%3.34M-50.25%2.79M-4.43%12.87M-65.85%1.92M-26.66%1.96M25.17%3.57M87.91%5.62M
Gross profit 67.49%31.45M1,616.39%22.72M-250.29%-2.18M-132.61%-2.58M51.91%12.87M129.20%18.78M-26.87%1.32M33.19%1.45M405.30%7.91M87.09%8.47M
Operating expense 13.79%81.03M27.48%12.06M65.07%27.98M-7.91%20.59M-22.97%18.12M19.86%71.21M-14.03%9.46M3.96%16.95M19.88%22.36M33.92%23.52M
Selling and administrative expenses 2.52%26.88M-11.04%5.4M23.93%7.49M3.67%6.69M-18.29%6.53M2.10%26.22M-20.80%6.06M-7.07%6.05M16.96%6.45M5.47%7.99M
-General and administrative expense 2.52%26.88M-11.04%5.4M23.93%7.49M3.67%6.69M-18.29%6.53M2.10%26.22M-20.80%6.06M-7.07%6.05M16.96%6.45M5.47%7.99M
Research and development costs 19.22%67.88M32.96%20.4M87.90%20.48M-12.60%13.91M-25.38%11.59M30.74%56.94M16.53%15.35M11.29%10.9M21.11%15.91M55.50%15.53M
Other operating expenses -14.96%-13.74M-----------------21.68%-11.95M----------------
Operating profit 5.44%-49.58M230.96%10.66M-94.65%-30.16M-60.37%-23.17M65.13%-5.25M-2.37%-52.43M11.50%-8.14M-1.86%-15.49M15.43%-14.45M-15.45%-15.05M
Net non-operating interest income expense 148.03%4.47M1,871.74%12.43M-510.15%-10.2M259.94%1.12M253.88%998.64K543.93%1.8M111.15%630.49K-48.16%2.49M-185.96%-697.5K-241.16%-648.98K
Non-operating interest income 148.03%4.47M73.18%886.95K-47.41%1.31M214.10%1.35M143.92%1.02M543.93%1.8M109.00%512.14K-48.36%2.5M-47.15%428.84K-9.49%416.14K
Non-operating interest expense --------117,834.03%11.51M-79.45%231.46K-98.46%16.41K---------74.29%9.76K--1.13M--1.07M
Other net income (expense) 124.46%646K-304.10%-2.64M
Gain on sale of security 124.46%646K-----------------304.10%-2.64M----------------
Income before tax 16.53%-44.46M333.88%23.74M-210.27%-40.36M-45.62%-22.06M72.93%-4.25M-7.30%-53.27M25.14%-10.15M-24.90%-13.01M6.93%-15.15M-24.83%-15.7M
Income tax -11.61%845K7.76%9.56M-43.12%-4.21M-17.10%-2.38M38.52%-1.88M38.95%956K27.99%8.87M-18.50%-2.94M-12.98%-2.03M-23.30%-3.06M
Net income 16.45%-45.31M174.51%14.17M-259.11%-36.15M-50.03%-19.68M81.26%-2.37M-7.74%-54.23M7.16%-19.02M-26.90%-10.07M9.40%-13.12M-25.21%-12.64M
Net income continuous Operations 16.45%-45.31M174.51%14.17M-259.11%-36.15M-50.03%-19.68M81.26%-2.37M-7.74%-54.23M7.16%-19.02M-26.90%-10.07M9.40%-13.12M-25.21%-12.64M
Minority interest income
Net income attributable to the parent company 16.45%-45.31M174.51%14.17M-259.11%-36.15M-50.03%-19.68M81.26%-2.37M-7.74%-54.23M7.16%-19.02M-26.90%-10.07M9.40%-13.12M-25.21%-12.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.45%-45.31M174.51%14.17M-259.11%-36.15M-50.03%-19.68M81.26%-2.37M-7.74%-54.23M7.16%-19.02M-26.90%-10.07M9.40%-13.12M-25.21%-12.64M
Basic earnings per share 32.65%-0.99160.89%0.3067-183.09%-0.7668-15.95%-0.421284.98%-0.0535.77%-1.4715.37%-0.5037-12.29%-0.270924.94%-0.3633-4.15%-0.353
Diluted earnings per share 32.65%-0.99160.89%0.3067-183.09%-0.7668-15.95%-0.421284.98%-0.0535.77%-1.4715.37%-0.5037-12.29%-0.270924.94%-0.3633-4.15%-0.353
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Cisco
CSCO
60.860
NVIDIA
NVDA
109.670
Broadcom
AVGO
169.120
4
Taiwan Semiconductor
TSM
165.250
5
ASML Holding
ASML
674.580
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings